ScholarIQanswers from OpenAlex & ORCID
Guido Marcucci
ResearcherPublications, citations & collaboration network
Guido Marcucci is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Guido Marcucci have?
ScholarIQindexed works
Guido Marcucci has 1,180 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Guido Marcucci have?
ScholarIQcitation count
Guido Marcucci has 54,763 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Guido Marcucci?
ScholarIQh-index
Guido Marcucci has an h-index of 118 in OpenAlex.
What is the i10-index of Guido Marcucci?
ScholarIQi10-index
Guido Marcucci has an i10-index of 453 in OpenAlex.
What is the ORCID of Guido Marcucci?
ScholarIQorcid
The ORCID for Guido Marcucci is on the source record.
What is the OpenAlex record for Guido Marcucci?
ScholarIQopenalex
The OpenAlex for Guido Marcucci is on the source record.
What are the most-cited papers on Guido Marcucci?
ScholarIQmost cited works
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su, Lei Dong, Yangchan Li, Min Gao, Li Han, Mark Wunderlich, Xiaolan Deng, Hongzhi Li, Yue Huang, Lei Gao, Chenying Li, Zhicong Zhao, Sean Robinson, Brandon Tan, Ying Qing, Xi Qin, Emily Prince, Jun Xie, Hanjun Qin, Wei Li, Chao Shen, Jie Sun, Prakash Kulkarni, Hengyou Weng, Huilin Huang, Zhenhua Chen, Bin Zhang, Xiwei Wu, Mark Olsen, Markus Müschen, Guido Marcucci, Ravi Salgia, Ling Li, Amir T. Fathi, Zejuan Li, James C. Mulloy, Minjie Wei, David Horne, Jianjun Chen
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
Margaret O’Donnell, Martin S. Tallman, Camille N. Abboud, Jessica K. Altman, Frederick R. Appelbaum, Daniel A. Arber, Vijaya Raj Bhatt, Dale L. Bixby, William Blum, Steven Coutré, Marcos de Lima, Amir T. Fathi, Melanie Fiorella, James M. Foran, Steven D. Gore, Aric C. Hall, Patricia Kropf, Jeffrey E. Lancet, Lori J. Maness, Guido Marcucci, Michael G. Martin, Joseph O. Moore, Rebecca L. Olin, Deniz Peker, Daniel A. Pollyea, Keith W. Pratz, Farhad Ravandi, Paul J. Shami, Richard M. Stone, Stephen A. Strickland, Eunice S. Wang, Matthew J. Wieduwilt, Kristina M. Gregory, Ndiya Ogba
Clinical response and <i>miR-29b</i> predictive significance in older AML patients treated with a 10-day schedule of decitabine
William Blum, Ramiro Garzon, Rebecca B. Klisovic, Sebastian Schwind, Alison Walker, Susan M. Geyer, Shujun Liu, Violaine Havelange, Heiko Becker, Larry J. Schaaf, Jon Mickle, Hollie Devine, Cheryl Kefauver, Steven M. Devine, Kenneth K. Chan, Nyla A. Heerema, Clara D. Bloomfield, Michael R. Grever, John C. Byrd, Miguel A. Villalona‐Calero, Carlo M. Croce, Guido Marcucci
Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia
Parvathi Ranganathan, Xueyan Yu, Caroline Na, Ramasamy Santhanam, Sharon Shacham, Michael Kauffman, Alison Walker, Rebecca B. Klisovic, William Blum, Michael A. Caligiuri, Carlo M. Croce, Guido Marcucci, Ramiro Garzon
Expression and prognostic impact of lncRNAs in acute myeloid leukemia
Ramiro Garzon, Stefano Volinia, Dimitrios Papaioannou, Deedra Nicolet, Jessica Kohlschmidt, Pearlly S. Yan, Krzysztof Mrózek, Donna Bucci, Andrew J. Carroll, Maria R. Baer, Meir Wetzler, Thomas H. Carter, Bayard L. Powell, Jonathan E. Kolitz, Joseph O. Moore, Ann-Kathrin Eisfeld, James S. Blachly, William Blum, Michael A. Caligiuri, Richard M. Stone, Guido Marcucci, Carlo M. Croce, John C. Byrd, Clara D. Bloomfield